<乌鸦传媒>First CDK4/6 Inhibitor OK'd for Early, High-Risk Breast Cancer Abemaciclib approved with endocrine therapy for hormone receptor-positive/HER2-negative disease Oct 13, 2021
<乌鸦传媒>Almost Half of Breast Cancer Patients Use Cannabis, Survey Finds Common reasons for use include pain, anxiety, nausea, and insomnia Oct 12, 2021
<乌鸦传媒>Women With Very Dense Breasts Benefit From MRI Screening Dutch researchers recommend screening with MRI every 4 years Oct 01, 2021
<乌鸦传媒>Different Taxanes, Similar Outcomes in Advanced HER2-Positive Breast Cancer Results from docetaxel-based study appear applicable to paclitaxel, nab-paclitaxel Sep 29, 2021
<乌鸦传媒>What's Behind the Racial Differences in Women's Cancer Screening? Existing medical conditions and social factors are likely driving gaps, researchers found Sep 24, 2021
<乌鸦传媒>In RA, Little Risk for Recurrent Cancer With Biologic Treatment Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<乌鸦传媒>Chemo Plus Keytruda Boosts Overall Survival in Advanced TNBC KEYNOTE-355 regimen offers "transformative treatment" in PD-L1-positive disease, expert says Sep 20, 2021
<乌鸦传媒>Combo Treatment Extends Survival in HR+HER2- Advanced Breast Cancer MONALEESA-2's "big message": 12.5-month boost in median OS with ribociclib-aromatase inhibitor Sep 19, 2021
<乌鸦传媒>Trastuzumab Deruxtecan: New Standard of Care in Pretreated, Advanced Breast Cancer? DESTINY-Breast03 turns in "absolutely startling" PFS in HER2-positive metastatic disease Sep 18, 2021
<乌鸦传媒>Extended Letrozole Reduced Recurrence Risk in Postmenopausal Breast Cancer 5 years of the aromatase inhibitor improved disease-free survival vs 2-3 years Sep 17, 2021
<乌鸦传媒>Improved Survival With Surgery in Metastatic Breast Cancer Significant benefits in ER+, PR+, HER2+ disease, neoadjuvant vs adjuvant chemotherapy Aug 31, 2021
<乌鸦传媒>Benefits of Adjuvant Radiation in DCIS Persist Out to 15 Years Risk of ipsilateral breast recurrence more than halved in women with good-risk lesions Aug 27, 2021
<乌鸦传媒>Dense Breasts Linked to Increased Risk of Invasive Cancer in Older Women Breast density, life expectancy could be factored into considerations for continued screening Aug 27, 2021
<乌鸦传媒>Genentech Pulls Atezolizumab's Breast Cancer Approval Lack of FDA support amid "changes in the treatment landscape" cited in decision Aug 27, 2021
<乌鸦传媒>Breast Cancer Control Similar With Intermittent, Continuous Endocrine Therapy Better quality of life with treatment break during extended adjuvant therapy Aug 11, 2021
<乌鸦传媒>A Patient Care App Diagnosed Me With Cancer No one should receive a serious diagnosis this way -- not even a doctor like myself Jul 16, 2021
<乌鸦传媒>Keytruda Before, After Surgery Improves Outcome in TNBC Results from KEYNOTE-522 show "practice-changing" impact on EFS Jul 15, 2021
<乌鸦传媒>Raise a Glass? Study Tallies Cancer Cases From Booze Heavy drinking habits accounted for about half of new alcohol-associated cases Jul 13, 2021
<乌鸦传媒>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival News, features, and commentary about cancer-related issues Jun 16, 2021
<乌鸦传媒>COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care? News, features, and commentary about cancer-related issues Jun 10, 2021
<乌鸦传媒>Bispecific Antibody Active in NRG1-Positive Pancreatic Cancer Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors Jun 10, 2021
<乌鸦传媒>More Support for Gene Assay to Guide Breast Cancer Treatment More nuanced data on treatment de-escalation, extended endocrine therapy Jun 09, 2021
<乌鸦传媒>Novel CDK 4/6 Inhibitor Proves Mettle in HR+/HER2- Advanced Breast Cancer Dalpiciclib may be a new treatment option; palbociclib and ribociclib continue to shine Jun 06, 2021
<乌鸦传媒>Olaparib Wins in Early BRCA-Mutant Breast Cancer First trial to show adjuvant PARP inhibitor benefit inBRCA mutation carriers Jun 03, 2021
<乌鸦传媒>Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<乌鸦传媒>RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancers Responses to selpercatinib in almost half of tumors outside approved indications May 21, 2021
<乌鸦传媒>Breast Cancer and MS: New Data Shed Light on Survival Study compares breast cancer patients with and without MS May 19, 2021
<乌鸦传媒>A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
<乌鸦传媒>Impressive Disease Control in Metastatic Triple-Negative Breast Cancer ESMO Breast: Reassuring safety data for dual anti-HER2 therapy, antibody-drug conjugate May 14, 2021
<乌鸦传媒>Chemo-Free Regimen Shows Promise in High-Risk Early Breast Cancer PFS and other outcomes with letrozole-palbociclib almost identical to chemotherapy May 12, 2021
<乌鸦传媒>SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
<乌鸦传媒>New Clues to Sleep Problems, Solutions in Cancer Patients Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
<乌鸦传媒>Healthy Lifestyle May Mitigate Heart Risks for Young Cancer Survivors Literature reviews find particularly persistent cardiovascular complications in these patients Apr 28, 2021
<乌鸦传媒>Chemotherapy Nausea Linked to Stress, Neuropsych Symptoms High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
<乌鸦传媒>Auricular Acupressure May Relieve Neuropathy in Breast Cancer First randomized trial of the noninvasive technique in such patients Apr 22, 2021
<乌鸦传媒>Are Post-Mastectomy Lymphedema Precautions Needed for All? Standard risk reduction efforts may not decrease incidence, researchers say Apr 21, 2021
<乌鸦传媒>Triple-Negative Breast Cancers Not All the Same Histology tied to treatment response, outcomes Apr 12, 2021
<乌鸦传媒>Safety Reassurance for Major Class of Diabetes Drugs Pooled trial data show no link to breast cancer Mar 24, 2021
<乌鸦传媒>Time to Revisit Distant Nodal Status in Breast Cancer Curability? Comparable survival for distant and regional nodal involvement, when treated similarly Mar 16, 2021
